Dasabuvir: An FDA-approved drug inhibiting poxvirus transmission by targeting both migrasome formation and extracellular enveloped virus production

Highlights•An FDA-approved drug dasabuvir inhibits vaccinia virus-induced migrasome formation•Dasabuvir reduces the plaque size of vaccinia virus•Dasabuvir inhibits extracellular enveloped virus production of vaccinia virus•Dasabuvir tends to associate with the palmitoylated F13